首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1694545篇
  免费   142149篇
  国内免费   7886篇
耳鼻咽喉   22807篇
儿科学   53993篇
妇产科学   47644篇
基础医学   239551篇
口腔科学   49188篇
临床医学   151258篇
内科学   329110篇
皮肤病学   35428篇
神经病学   135475篇
特种医学   68261篇
外国民族医学   516篇
外科学   255470篇
综合类   53634篇
现状与发展   17篇
一般理论   551篇
预防医学   128974篇
眼科学   39110篇
药学   130943篇
  54篇
中国医学   7712篇
肿瘤学   94884篇
  2018年   17601篇
  2017年   14275篇
  2016年   15322篇
  2015年   18608篇
  2014年   25167篇
  2013年   35851篇
  2012年   48895篇
  2011年   51463篇
  2010年   30842篇
  2009年   29111篇
  2008年   47628篇
  2007年   49781篇
  2006年   50387篇
  2005年   48564篇
  2004年   46880篇
  2003年   44879篇
  2002年   43653篇
  2001年   80109篇
  2000年   82615篇
  1999年   70213篇
  1998年   19508篇
  1997年   17711篇
  1996年   17225篇
  1995年   16809篇
  1994年   15733篇
  1993年   14757篇
  1992年   57167篇
  1991年   55337篇
  1990年   53934篇
  1989年   52150篇
  1988年   48418篇
  1987年   47621篇
  1986年   45216篇
  1985年   43631篇
  1984年   32548篇
  1983年   27982篇
  1982年   16363篇
  1981年   14605篇
  1979年   30719篇
  1978年   21141篇
  1977年   17823篇
  1976年   16745篇
  1975年   17635篇
  1974年   21549篇
  1973年   20759篇
  1972年   18917篇
  1971年   17824篇
  1970年   16339篇
  1969年   15318篇
  1968年   13991篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Hypertrophic lichen planus (HLP) is a T‐cell‐mediated process typically presenting with hypertrophic or verrucous plaques on the lower limbs. We report the case of a 24‐year‐old woman with a history of HLP since age 3 years presenting with rapid malignant transformation of one lesion into a large squamous cell carcinoma (SCC). Subsequent examination revealed progressive, widespread metastatic involvement, and the patient ultimately died from her disease. SCC associated with HLP is rare, with a review of the literature revealing fewer than 50 cases. This case highlights the need to be aware of suspicious changes in HLP and to educate patients as to when to be reevaluated.  相似文献   
102.
103.
104.
105.
106.
107.
108.
109.
Thyroid diseases are common, and use of levothyroxine is increasing worldwide. We investigated the influence of gender, race and socioeconomic status on the diagnosis and treatment of thyroid disorders using data from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), a multicenter cohort study of civil servants (35-74 years of age) from six Brazilian cities. Diagnosis of thyroid dysfunction was by thyrotropin (TSH), and free thyroxine (FT4) if TSH was altered, and the use of specific medications. Multivariate logistic regression models were constructed using overt hyperthyroidism/hypothyroidism and levothyroxine use as dependent variables and sociodemographic characteristics as independent variables. The frequencies of overt hyper- and hypothyroidism were 0.7 and 7.4%, respectively. Using whites as the reference ethnicity, brown, and black race were protective for overt hypothyroidism (OR=0.76, 95%CI=0.64-0.89, and OR=0.53, 95%CI=0.43-0.67, respectively, and black race was associated with overt hyperthyroidism (OR=1.82, 95%CI=1.06-3.11). Frequency of hypothyroidism treatment was higher in women, browns, highly educated participants and those with high net family incomes. After multivariate adjustment, levothyroxine use was associated with female gender (OR=6.06, 95%CI=3.19-11.49) and high net family income (OR=3.23, 95%CI=1.02-10.23). Frequency of hyperthyroidism treatment was higher in older than in younger individuals. Sociodemographic factors strongly influenced the diagnosis and treatment of thyroid disorders, including the use of levothyroxine.  相似文献   
110.
Coronavirus disease 2019 (COVID-19) has resulted in many challenges in patient care, especially among high-risk populations such as heart transplant recipients. Patients with heart transplant experience a significantly higher mortality rate with COVID-19 infection, and management is based on extrapolation from clinical trials done on nontransplant patients and from clinical experience. Here we report 4 cases of patients with heart transplant who presented with COVID-19 infection in late 2020. Patients presented with symptoms similar to those seen in the general population. All 4 patients were admitted to the hospital, and they were all treated with dexamethasone. In addition, 2 patients received remdesivir. Immunosuppressive medications were adjusted to maintain adequate levels of immunosuppression but at the same time allow for an adequate immune response against the infection. All patients were discharged alive from the hospital. We then performed a literature review on studies that included heart transplant patients who developed the infection and developed suggestions for a standardized management approach, which we share in this article.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号